Antihypertensive therapy--going to the heart of the matter.
1990; Lippincott Williams & Wilkins; Volume: 81; Issue: 3 Linguagem: Inglês
10.1161/01.cir.81.3.1128
ISSN1524-4539
Autores Tópico(s)Cardiac Fibrosis and Remodeling
ResumoHomeCirculationVol. 81, No. 3Antihypertensive therapy--going to the heart of the matter. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBAntihypertensive therapy--going to the heart of the matter. F H Messerli F H MesserliF H Messerli Department of Internal Medicine, Ochsner Clinic, New Orleans, Louisiana. Originally published1 Mar 1990https://doi.org/10.1161/01.CIR.81.3.1128Circulation. 1990;81:1128–1135 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Rizzi É, Castro M, Prado C, Silva C, Fazan R, Rossi M, Tanus-Santos J and Gerlach R (2010) Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension, Journal of Cardiac Failure, 10.1016/j.cardfail.2010.02.005, 16:7, (599-608), Online publication date: 1-Jul-2010. NAKAGAMI H, KIKUCHI Y, KATSUYA T, MORISHITA R, AKASAKA H, SAITOH S, RAKUGI H, KANEDA Y, SHIMAMOTO K and OGIHARA T (2007) Gene Polymorphism of Myospryn (Cardiomyopathy-Associated 5) Is Associated with Left Ventricular Wall Thickness in Patients with Hypertension, Hypertension Research, 10.1291/hypres.30.1239, 30:12, (1239-1246), . (2005) Franz H. Messerli, MD: A Conversation With the Editor⁎⁎This series of interviews is underwritten by an unrestricted grant from Bristol-Myers Squibb., The American Journal of Cardiology, 10.1016/j.amjcard.2005.03.022, 96:1, (154-165), Online publication date: 1-Jul-2005. Messerli F and Mehra M (2002) Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [life] study), The American Journal of Cardiology, 10.1016/S0002-9149(02)02782-0, 90:10, (1133-1134), Online publication date: 1-Nov-2002. Pittrow D, Weidinger G, Stoerk T and Eichstaedt H (2002) Impact of a Low-Dose Combination of Isradipine SRO and Spirapril on Left Ventricular Mass and Left Ventricular Performance in Patients with Hypertension and Left Ventricular Hypertrophy, Clinical Drug Investigation, 10.2165/00044011-200222100-00003, 22:10, (667-675), . Delles C, Erdmann J, Jacobi J, Hilgers K, Fleck E, Regitz-Zagrosek V and Schmieder R (2001) Aldosterone synthase (CYP11B2) −344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension, Journal of the American College of Cardiology, 10.1016/S0735-1097(00)01174-8, 37:3, (878-884), Online publication date: 1-Mar-2001. Schmieder R, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K and Regitz-Zagrosek V (2001) Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans, Journal of the American College of Cardiology, 10.1016/S0735-1097(00)01063-9, 37:1, (175-182), Online publication date: 1-Jan-2001. Klingbeil A, Muller H, Delles C, Fleischmann E and Schmieder R (2000) Regression of left ventricular hypertrophy by at1 receptor blockade in renal transplant recipients, American Journal of Hypertension, 10.1016/S0895-7061(00)01213-9, 13:12, (1295-1300), Online publication date: 1-Dec-2000. Frank H, Schmieder R, Vogt-Ladner G, Schobel H and Neumayer H (2000) Determinants of left ventricular structure after kidney transplantation, Transplantation Proceedings, 10.1016/S0041-1345(00)01891-1, 32:8, (2801-2806), Online publication date: 1-Dec-2000. Zimmer H, Zierhut W and Irlbeck M (1998) Effect of Angiotensin-Converting Enzyme Inhibition and of Angiotension II Receptor Blockade on the Development of Cardiac Hypertrophy in Rats Angiotensin II Receptor Blockade Physiological and Clinical Implications, 10.1007/978-1-4615-5743-2_23, (311-322), . Trenkwalder P, Plaschke M, Aulehner R and Lydtin H (2009) Felodipine or Hydrochlorothiazide/Triamterene for Treatment of Hypertension in the Elderly: Effects on Blood Pressure, Hypertensive Heart Disease, Metabolic and Hormonal Parameters, Blood Pressure, 10.3109/08037059609062124, 5:3, (154-163), Online publication date: 1-Jan-1996. Carey P, Sheridan D, de Cordoue A and Guez D (1996) Effect of indapamide on left ventricular hypertrophy in hypertension: A meta-analysis, The American Journal of Cardiology, 10.1016/S0002-9149(97)89234-X, 77:6, (B17-B19), Online publication date: 1-Feb-1996. Noel H and Demper J (1994) Essential Hypertension: Pathophysiology, Journal of the American Academy of Nurse Practitioners, 10.1111/j.1745-7599.1994.tb00962.x, 6:7, (322-333), Online publication date: 1-Jul-1994. Scott A (2008) Hypertension in elderly people, Reviews in Clinical Gerontology, 10.1017/S0959259800003713, 4:2, (113-130), Online publication date: 1-May-1994. Noel H and Dempster J (1994) Essential Hypertension: Evaluation and Treatment, Journal of the American Academy of Nurse Practitioners, 10.1111/j.1745-7599.1994.tb00981.x, 6:9, (421-435), Online publication date: 1-Sep-1994. Arnett D, Rautaharju P, Crow R, Folsom A, Ekelund L, Hutchinson R, Tyroler H, Heiss G and The ARIC Investigators (1994) Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC study), The American Journal of Cardiology, 10.1016/0002-9149(94)90365-4, 74:3, (247-252), Online publication date: 1-Aug-1994. Messerli F, Soria F and Aristizabal D (1993) Left ventricular hypertrophy: Should it be reduced?, Clinical Cardiology, 10.1002/clc.4960161405, 16:S2, (15-20), Online publication date: 1-May-1993. Weidmann P, Boehlen L and de Courten M (1993) Pathogenesis and treatment of hypertension associated with diabetes mellitus, American Heart Journal, 10.1016/0002-8703(93)90447-H, 125:5, (1498-1513), Online publication date: 1-May-1993. Messerli F, Aristizabal D and Soria F (1993) Reduction of left ventricular hypertrophy: How beneficial?, American Heart Journal, 10.1016/0002-8703(93)90449-J, 125:5, (1520-1524), Online publication date: 1-May-1993. Kostis J, Shindler D, Moreyra A, Ruddy M, Schneider S and Cosgrove N (2016) Differential Exercise Effects of Captopril and Nadolol in Patients with Essential Hypertension, Angiology, 10.1177/000331979204300804, 43:8, (647-652), Online publication date: 1-Aug-1992. Rossi M and Peres L (1992) Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy, American Heart Journal, 10.1016/0002-8703(92)90281-Y, 124:3, (700-709), Online publication date: 1-Sep-1992. Messerli F and Soria F (1992) Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death, The American Journal of Medicine, 10.1016/0002-9343(92)90291-I, 93:2, (S21-S26), Online publication date: 1-Aug-1992. Mervaala E, Himberg J, Laakso J, Tuomainen P and Karppanen H (1992) Beneficial effects of a potassium- and magnesium-enriched salt alternative., Hypertension, 19:6_pt_1, (535-540), Online publication date: 1-Jun-1992. Gorlin R (1991) Do we need another antihypertensive agent?, American Heart Journal, 10.1016/0002-8703(91)90444-M, 121:2, (670-676), Online publication date: 1-Feb-1991. Rudin M, Pedersen B, Umemura K and Zierhut W (1991) Determination of rat heart morphology and function in vivo in two models of cardiac hypertrophy by means of magnetic resonance imaging, Basic Research in Cardiology, 10.1007/BF02190549, 86:2, (165-174), Online publication date: 1-Mar-1991. Houghton J, Prisant L, Carr A, von Dohlen T and Frank M (1991) Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease, American Heart Journal, 10.1016/0002-8703(91)90669-9, 121:4, (1107-1112), Online publication date: 1-Apr-1991. Zierhut W, Zimmer H and Gerdes A (1991) Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats., Circulation Research, 69:3, (609-617), Online publication date: 1-Sep-1991. (1990) Left Ventricular Hypertrophy in Hypertension, New England Journal of Medicine, 10.1056/NEJM199011013231812, 323:18, (1276-1279), Online publication date: 1-Nov-1990. March 1, 1990Vol 81, Issue 3 Advertisement Article InformationMetrics Copyright © 1990 by American Heart Associationhttps://doi.org/10.1161/01.CIR.81.3.1128 Originally publishedMarch 1, 1990 PDF download Advertisement
Referência(s)